Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Takeda Pharmaceutical Company Limited”

1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,022
Index total 30,257
Page 23 / 43

Quick answer

This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,022 results for “Takeda Pharmaceutical Company Limited” · 30,257 patents in full index Clear search

  1. US 9085578

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  2. US 9079907

    Fused heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 14, 2015 · Expires Jul 9, 2035

    granted

  3. US 9073864

    Aromatic ring compound

    Takeda Pharmaceutical Company Limited · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  4. US 9073918

    Pyrazolo[4,3-b]pyridine-7-amine inhibitors of ALK5

    Takeda Pharmaceutical Company Limited · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  5. US 9066936

    Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a pH control agent

    Takeda Pharmaceutical Company Limited · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  6. US 9060941

    Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

    Takeda Pharmaceutical Company Limited · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  7. US 9056873

    Substituted 6-aza-isoindolin-1-one derivatives

    Takeda Pharmaceutical Company Limited · Granted Jun 16, 2015 · Expires Jun 11, 2035

    granted

  8. US 9045436

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  9. US 9045496

    N-substituted oxazinopteridines and oxazinopteridinones

    Takeda Pharmaceutical Company Limited · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  10. US 9044483

    Cell death inhibition by macrophage migration inhibitory factor and a binding substance thereto

    Takeda Pharmaceutical Company Limited · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  11. US 9040522

    6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

    Takeda Pharmaceutical Company Limited · Granted May 26, 2015 · Expires May 21, 2035

    granted

  12. US 9029388

    Condensed heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted May 12, 2015 · Expires May 7, 2035

    granted

  13. US 9029536

    Fused heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted May 12, 2015 · Expires May 7, 2035

    granted

  14. US 9023858

    Substituted pyrido[2,3-d]pyrimidines as delta-5-desaturase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 5, 2015 · Expires Apr 30, 2035

    granted

  15. US 9018374

    Crystal of amide compound

    Takeda Pharmaceutical Company Limited · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  16. US 9012447

    5-HT3 receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  17. US 9011926

    Method for producing granules

    Takeda Pharmaceutical Company Limited · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  18. US 9006201

    Prophylactic or therapeutic agent for diabetes

    Takeda Pharmaceutical Company Limited · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted

  19. US 8993598

    Pyrrole compounds

    Takeda Pharmaceutical Company Limited · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  20. US 8980322

    Controlled release composition

    Takeda Pharmaceutical Company Limited · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted

  21. US 8980902

    Poly (ADP-ribose) polymerase (PARP) inhibitors

    Takeda Pharmaceutical Company Limited · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted

  22. US 8969387

    Pyrrole compounds

    Takeda Pharmaceutical Company Limited · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted

  23. US 8957070

    Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity

    Takeda Pharmaceutical Company Limited · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted

  24. US 8957069

    Benzofuran derivatives

    Takeda Pharmaceutical Company Limited · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.